epocrates: Drug Info & Pill ID vs Monash FODMAP Diet
Revenue, downloads, ratings and category context for two iOS apps. Figures are estimates and should be read as ranges, not exact totals.
epocrates: Drug Info & Pill IDEpocrates - Medical
Monash FODMAP DietMonash University - Medical| Metric | epocrates: Drug Info & Pill ID | Monash FODMAP Diet | Readout |
|---|---|---|---|
| Estimated revenue / mo | $*** - opens with trial | $*** - opens with trial | epocrates: Drug Info & Pill ID |
| Revenue band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Estimated downloads / mo | $*** - opens with trial | $*** - opens with trial | epocrates: Drug Info & Pill ID |
| Download band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Rating | 4.44 | 4.23 | epocrates: Drug Info & Pill ID |
| Rating count | 7.1k | 2.6k | epocrates: Drug Info & Pill ID |
| Tracked keywords | 1 | — | epocrates: Drug Info & Pill ID |
| Category | Medical | Medical | Same market |
Which app is bigger?
epocrates: Drug Info & Pill ID and Monash FODMAP Diet are compared inside Medical with monthly revenue, downloads, rating, review volume, keyword footprint, category placement and range context. epocrates: Drug Info & Pill ID leads on monthly downloads in the current readout, and epocrates: Drug Info & Pill ID wins the revenue readout (the exact figures open with the paid plan), epocrates: Drug Info & Pill ID wins demand, epocrates: Drug Info & Pill ID has deeper review volume, and epocrates: Drug Info & Pill ID has the larger tracked keyword footprint. The better app depends on the job: choose the revenue leader when you need monetization proof, choose the download leader when reach matters, and choose the higher-rated or deeper-reviewed app when market trust is the constraint. Read both ranges rather than only the midpoint, then open the category hub and related collections to see whether this pair is an outlier or a normal category pattern.